FDA grants AP status for Leuprolide Acetate ANDA075471 by Meitheal
The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Leuprolide Acetate submitted by Meitheal.
Asset / Drug
Drug and asset intelligence for Meitheal with 7 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Hormonal Therapy
The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Haloperidol Decanoate submitted by Meitheal.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.